Cargando…

Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trial

AIM/HYPOTHESIS: To assess whether low-dose glucocorticoid treatment induces adverse metabolic effects, as is evident for high glucocorticoid doses. METHODS: In a randomised placebo-controlled double-blind (participants and the investigators who performed the studies and assessed the outcomes were bl...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Raalte, D. H., Brands, M., van der Zijl, N. J., Muskiet, M. H., Pouwels, P. J. W., Ackermans, M. T., Sauerwein, H. P., Serlie, M. J., Diamant, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131514/ https://www.ncbi.nlm.nih.gov/pubmed/21562755 http://dx.doi.org/10.1007/s00125-011-2174-9

Ejemplares similares

Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial
por: Smits, Mark M., et al.
Publicado: (2016)

Acute plasma amylase increase after glucagon‐like peptide ‐1 receptor agonist exenatide administration in Type 2 diabetes
por: Smits, M. M., et al.
Publicado: (2017)

Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in type 2 diabetes
por: Smits, Mark M, et al.
Publicado: (2015)

Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia
por: Visser, M. E., et al.
Publicado: (2011)

Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial
por: Tonneijck, Lennart, et al.
Publicado: (2016)

Glucagon-Like Peptide-1 Receptor Agonist Treatment Prevents Glucocorticoid-Induced Glucose Intolerance and Islet-Cell Dysfunction in Humans
por: van Raalte, Daniël H., et al.
Publicado: (2011)

A Major Role for Perifornical Orexin Neurons in the Control of Glucose Metabolism in Rats
por: Yi, Chun-Xia, et al.
Publicado: (2009)

The Intermediary Metabolism of Pyrene
por: Harper, K. H.
Publicado: (1958)

Dietary saturated fat/cholesterol, but not unsaturated fat or starch, induces C-reactive protein associated early atherosclerosis and ectopic fat deposition in diabetic pigs
por: Koopmans, Sietse J, et al.
Publicado: (2011)

The effect of dapagliflozin on apolipoprotein B and glucose fluxes in patients with type 2 diabetes and well‐controlled plasma LDL cholesterol
por: Bouter, Kristien E. C., et al.
Publicado: (2020)

Intermediary Metabolism in HeLa and Human Foetal Liver Cells
por: Bryant, C., et al.
Publicado: (1963)

The Intermediary Metabolism of Polycyclic Hydrocarbons
por: Harper, K. H.
Publicado: (1959)

Biliary effects of liraglutide and sitagliptin, a 12‐week randomized placebo‐controlled trial in type 2 diabetes patients
por: Smits, Mark M., et al.
Publicado: (2016)

Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39:2042–2050
por: Tonneijck, Lennart, et al.
Publicado: (2019)

The Intermediary Metabolism of 3:4-Benzpyrene
por: Harper, K. H.
Publicado: (1958)

Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial
por: de Jong, P H, et al.
Publicado: (2014)

Short‐Term Glucocorticoid Treatment Reduces Circulating Sclerostin Concentrations in Healthy Young Men: A Randomized, Placebo‐Controlled, Double‐Blind Study
por: Jacobsson, Merel, et al.
Publicado: (2020)

Metabolic changes in type 2 diabetes are reflected in peripheral blood cells, revealing aberrant cytotoxicity, a viral signature, and hypoxia inducible factor activity
por: van der Pouw Kraan, Tineke C. T. M., et al.
Publicado: (2015)

Intermediary metabolism of the lung.
por: Fisher, A B
Publicado: (1984)

Between biology and medicine: the formation of intermediary metabolism
por: Tansey, E. M.
Publicado: (1994)

The regulation of cardiac intermediary metabolism by NADPH oxidases
por: Nabeebaccus, Adam A, et al.
Publicado: (2022)

Light therapy for better mood and insulin sensitivity in patients with major depression and type 2 diabetes: a randomised, double-blind, parallel-arm trial
por: Brouwer, Annelies, et al.
Publicado: (2015)

Skin microvascular function and renal hemodynamics in overweight patients with type 2 diabetes: A cross‐sectional study
por: Bouman, Emma J., et al.
Publicado: (2021)

Effects of dipeptidyl peptidase‐4 inhibitor linagliptin versus sulphonylurea glimepiride on systemic haemodynamics in overweight patients with type 2 diabetes: A secondary analysis of an 8‐week, randomized, controlled, double‐blind trial
por: Kraaijenhof, Jordan, et al.
Publicado: (2020)

Sarcoplasmic reticulum is an intermediary of mitochondrial and myofibrillar growth at the intercalated disc
por: Bennett, Pauline M., et al.
Publicado: (2016)

Erratum. SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management. Diabetes Care 2018;41:1543–1556
por: van Baar, Michaël J.B., et al.
Publicado: (2019)

Valsartan Improves β-Cell Function and Insulin Sensitivity in Subjects With Impaired Glucose Metabolism: A randomized controlled trial
por: van der Zijl, Nynke J., et al.
Publicado: (2011)

Glucocorticoids induce differentiation of monocytes towards macrophages that share functional and phenotypical aspects with erythroblastic island macrophages
por: Heideveld, Esther, et al.
Publicado: (2018)

Increase in prophylaxis of glucocorticoid-induced osteoporosis by pharmacist feedback: a randomised controlled trial
por: Klop, C., et al.
Publicado: (2013)

Glucocorticoid Signaling in the Arcuate Nucleus Modulates Hepatic Insulin Sensitivity
por: Yi, Chun-Xia, et al.
Publicado: (2012)

Plasma uric acid and renal haemodynamics in type 2 diabetes patients
por: Suijk, Danii LS, et al.
Publicado: (2019)

Developing the agroecological niche in Nicaragua: The roles of knowledge flows and intermediaries
por: Schiller, Katharina J. F., et al.
Publicado: (2023)

Glucocorticoid sensitivity in Behçet's disease
por: Quax, R A M, et al.
Publicado: (2012)

High-Target Hemodiafiltration Convective Dose Achieved in Most Patients in a 6-Month Intermediary Analysis of the CONVINCE Randomized Controlled Trial
por: Vernooij, Robin W.M., et al.
Publicado: (2023)

Differential impact of subclinical carotid artery disease on cerebral structure and functioning in type 1 diabetes patients with versus those without proliferative retinopathy
por: van Duinkerken, Eelco, et al.
Publicado: (2014)

Social Features of Online Networks: The Strength of Intermediary Ties in Online Social Media
por: Grabowicz, Przemyslaw A., et al.
Publicado: (2012)

Autoantibodies to transcription intermediary factor (TIF)1β associated with dermatomyositis
por: Satoh, Minoru, et al.
Publicado: (2012)

Efficacy and safety of selective glucocorticoid receptor modulators in comparison to glucocorticoids in arthritis, a systematic review
por: Safy, M., et al.
Publicado: (2017)

The Fate and Intermediary Metabolism of Soyasapogenol in the Rat
por: Pan, Chenghui, et al.
Publicado: (2022)

Humic Substances as a Versatile Intermediary
por: Hriciková, Simona, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dfmt9iji9942jk560sh0qp3su8